Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

In the end, ChatGPT Advanced Voice is a step forward, but it's a much smaller step than what we were promised. It's a ...

Neuren Pharmaceuticals (ASX:NEU), an Australian biotech focused on developing treatments for neurological disorders, has ...

These recommendations reflect evidence suggesting that low brain iron is an important underlying cause of RLS ... In contrast ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...